St. Louis, United States
Appistry is a scientific software company founded in 2001 and headquartered in the United States. Specializing in Analytics and Biotechnology, the company aims to bridge the gap between genomic data and health outcomes. Its focus is on making next-generation sequencing analysis more approachable and actionable to improve clinical decisions. With a background in high-performance computing, big data, and life sciences, Appistry offers a unique level of expertise to help customers solve complex problems and transform data into actionable information.
The company's most recent investment was a significant $10.25M Debt Financing round, which took place on 20 February 2015.
Although specific information about the investors involved in the latest funding round is not provided, Appistry's dedication to leveraging technology for meaningful advancements in healthcare and life sciences presents an intriguing opportunity for potential investors seeking to support companies at the forefront of genomic data analysis and its application to clinical decision making.
